非侵入性低水平的气刺激减轻了急性心力衰竭中的炎症和氧化应激
Tarun W Dasari1, Praloy Chakraborty2, Peter Mukli3
1Cardiovascular Section, Department of Internal Medicine, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, 800 SL Young Blvd, COM 5400, Oklahoma City, OK, 73104, USA. tarun-dasari@ouhsc.edu.
概括
使用非侵入性气刺激的神经调节可减少急性失补性心力衰竭 (ADHF) 患者的炎症和氧化应激. 这项安全的概念验证研究显示了新型ADHF治疗的潜力.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 急性不补偿性心力衰竭 (ADHF) 涉及炎症,氧化应激和交感神经系统过度活动.
- 神经调节减轻ADHF中这些病理过程的潜力在很大程度上仍未被探索.
研究的目的:
- 调查非侵入性低级别气道刺激 (神经调节) 在降低ADHF患者的炎症和氧化应激的疗效.
- 评估这种神经调节方法在急性心力衰竭环境中的可行性和安全性.
主要方法:
- 一项随机的概念验证研究,涉及19名因ADHF住院的减排分数 (<40%) 患者.
- 患者每天两次接受主动神经调节 (n=8) 或假刺激 (n=11),并接受标准护理.
- 在入院和出院时测量了血清细胞因子素水平 (互乐金-6) 和内皮细胞氧化应激.
主要成果:
- 神经调节显著降低了血清中白素-6水平78%,而假药组的降低率为9% (p=0.012).
- 在神经调节组 (p=0.003) 中,内皮细胞氧化应激显著减弱,但在假药组 (p=0.094) 中没有显著减弱.
- 两组之间没有观察到心率,血压或功能的显著差异,这表明安全性.
结论:
- 通过轨道刺激进行非侵入性神经调节是ADHF患者的可行和安全的干预措施.
- 这种方法有效地减少了全身炎症和冠状动脉内皮氧化应激.
- 这些发现支持进一步研究神经调节作为ADHF的治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
01:22Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
01:30Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9